Skip to main content
. Author manuscript; available in PMC: 2021 Jun 1.
Published in final edited form as: Leuk Lymphoma. 2020 Feb 8;61(6):1484–1492. doi: 10.1080/10428194.2020.1719095

Table 1.

Adult cohort induction regimen.

Dose level
(DL)
AR-42 Decitabine
1 20 mg po daily days 1,3,5
2 40 mg po daily days 1,3,5 20 mg/m2/d IV days 6–15
3 40 mg po daily days 1,3,4,5

Dosing regimens for AR-42 and decitabine by dose level. Three patients enrolled to DL1, 3 to DL2 and 6 to DL 3.